Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning: A Pharmacological fMRI Study.

Trial Profile

Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning: A Pharmacological fMRI Study.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Jun 2011

At a glance

  • Drugs Aripiprazole (Primary) ; Haloperidol (Primary)
  • Indications Attention-deficit hyperactivity disorder; Behavioural disorders; Bipolar disorders; Depressive disorders; Gilles de la Tourette's syndrome; Psychotic disorders; Schizophrenia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 23 Aug 2010 Actual initiation date added to 1 Aug 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top